experimental group:Camrelizumab combined with TACE

2 trials

Sponsors

Hu'nan Provincial People's Hospital, Shandong Cancer Prevention and Treatment Institute

Conditions

Hepatocellular CarcinomaHepatocellular carcinoma

Early Phase 1

A randomized, controlled, open-label clinical study of Transcatheter Arterial Chemoembolization (TACE) combined with Camrelizumab in the treatment of advanced Hepatocellular Carcinoma

RecruitingChiCTR2000031904

Shandong Cancer Prevention and Treatment InstituteHepatocellular Carcinoma

Start: 2020-04-15Updated: 2020-04-20

Phase 4

A prospective, multicenter, non-interventional and observational clinical study of Camrelizumab for injection combined with TACE in the treatment of advanced hepatocellular carcinoma patients

RecruitingChiCTR2000031808

Hu'nan Provincial People's HospitalHepatocellular carcinoma

Start: 2020-05-01Updated: 2021-09-28